SECTION 1. Chapter 94C of the General Laws is hereby amended by inserting after section 18C the following new section:-

Section 18D. In the event that a practitioner issues a prescription for an opioid contained in Schedule II of section 3, the practitioner shall also provide education on the potential adverse risks of the prescription opioid, including the need to also obtain an opioid overdose reversal agent, such as naloxone, if one of the following conditions is present: (i) the patient is prescribed an opioid which individually or in aggregate with other medications is more than equal to 50 morphine milligram 7 equivalents per day; (ii) the patient is prescribed any dose of an opioid when a benzodiazepine has been prescribed in the past 30 days or will be prescribed at the visit; or (iii) the patient has a prior history of opioid use disorder or overdose or has a history of substance use disorder. If the practitioner does not provide this education on an opioid antagonist at the time said prescription for an opioid is issued, the practitioner shall document in the patient’s medical record why an opioid antagonist was not appropriate for the patient.